KLACKLA CorporationTechnology · Semiconductorsas of 2026-08-13
Horizon

Issued 2026-08-13 at $209.37 · now $209.37 (2026-08-13, +0.0% since)

Based on its own history, a month from the 2026-08-13 close, KLAC has typically landed between $179.19 and $256.22 — a range of −14.4% to +22.4% from the issuance price $209.37.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

4,662 overlapping 1 month windows · 2008-01-022026-07-15 · basis climatology · forecast (batch). Probability up 53.8% (90% CI 51.656.0%, ≈1,400 obs).

The cone is anchored at the 2026-08-13 issuance close ($209.37) — the price the forecast resolves against on 2026-09-11, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where KLAC has typically landed a month from the 2026-08-13 close of $209.37 — the range is history, not a prediction.

$179.19worst · -14.4%$256.22best · +22.4%
  • now $209.37 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $215.3 (+2.8%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $200.13$230.48
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $179.19$256.22
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 4,662 windows spanning 2008-01-02 to 2026-08-13. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2008-09-25−41.7%−41.7%+3.4%
2008-09-26−40.9%−43.6%+0.0%
2026-06-30−40.2%−43.6%+0.0%
3 best
2026-05-29+57.0%+0.0%+57.0%
2026-05-19+49.1%+0.0%+49.1%
2026-05-20+47.1%+0.0%+47.1%

4,662 overlapping windows · 2008-01-022026-08-13 · not cherry-picked

Fundamentals iCompany financials — revenue, earnings, margins — from the newest filings shown, each carried with its date.iAs-reported figures and standard ratios from FMP, as of 2026-07-25. Revenue, net income and free cash flow can toggle annual or quarterly; margin, ROE and debt-to-equity are shown by fiscal year. We report the figures and the trend — no target price and no over/under-valued call. More on /methodology.

$275.0B
market cap
$3.53
EPS (TTM)
59.6
P/E (TTM)
2026-07-28
next earnings
Revenue$12.2B
'20'25
Net income$4.1B
'20'25
Free cash flow$3.7B
'20'25
Net margin · by yr33.4%
'20'25
ROE · by yr86.6%
'20'25
Debt / equity · by yr1.30
'20'25

Fair value — three views iIndependent reference estimates of worth (a cash-flow model, peer multiples, analyst targets), shown as separate views — not a single verdict.

iThree independent estimates of per-share value, each by a different method and each with its own assumptions: a discounted-cash-flow intrinsic value, a peer comparable (the median trailing P/E of 80 sector peers times this company's trailing EPS), and the analyst price-target consensus. They routinely disagree — that gap is the point. We show the three marks and the current price; we do not blend them into a single number or call the stock over- or under-valued. Marks as of the latest capture. More on /methodology.
now $209.37$41.28$346.02
  • DCF (intrinsic)$62.30
  • Peer P/E × EPS · sector median 34.2× · n=80$120.78
  • Analyst target · range $145.00$325.00$200.00
  • Current price · last close 2026-08-13$209.37

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~19 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
61%
+2.7%
n=18
Feb
68%
+2.3%
n=19
Mar
58%
+1.6%
n=19
Apr
53%
+3.4%
n=19
May
74%
+3.4%
n=19
Jun
53%
+3.4%
n=19
Jul
63%
+3.2%
n=19
Aug
32%
−0.8%
n=19
Sep
50%
+2.0%
n=18
Oct
72%
+3.0%
n=18
Nov
44%
+3.7%
n=18
Dec
78%
+3.6%
n=18

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-082025-07$302$842026-08-12: 1 insider sale, $6.6M — Higgins Bren D.2025-08-20: 1 insider sale, $2.0M — Higgins Bren D.2025-08: 1 open-market sale, $2.0M↑ buys↓ salesofficer Higgins Bren D. — Sale on 2026-08-12, filed 1 day after the tradeofficer Higgins Bren D. — Sale on 2025-08-20, filed 2 days after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-08-12Higgins Bren D.officerSale31,500 @ $209.87$6.6M−9.3% of holdingnot yet — horizon still opennot yet — horizon still open307,815Form 4 · filed 1 day after the trade
2025-08-20Higgins Bren D.officerSale2,301 @ $878.53$2.0M−6.3% of holding+14.6%+62.1%34,408Form 4 · filed 2 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures iStock trades disclosed by members of Congress for this company, by the date they were filed.iDisclosures shown as facts. A purchase “cluster” (≥2 members of Congress filing a buy within 90 days) has historically preceded modestly higher forward returns — and it persisted out-of-sample, though it roughly halved after 2021 (see below). A descriptive historical tendency, not a signal to trade and not used in our forecast. See /methodology.

As of 2026-08-13 · point-in-time by filed date

Purchase clusters · 2015–2021 (dev)+45 bp/mo vs baseline · up-rate 59.3% vs 57.3% · n=31,607 cluster ticker-weeks
Purchase clusters · 2022–2026 (out-of-sample)+28 bp/mo vs baseline · up-rate 53.7% vs 53.2% · n=26,833

A cluster = ≥2 members of Congress filing a purchase within 90 days. The historical tilt persisted after 2021 but roughly halved (+45 → +28 bp/mo forward 1-month vs the S&P 500 weekly-grid baseline). Descriptive historical tendency — not a signal to trade, and not used in our forecast (audition-log 2026-07-27).

'23 Q'24 Q'24 Q'24 Q'24 Q'25 Q'25 Q'25 Q'25 Q'26 Q'26 Q'26 Qpurchases ▲ / sales ▼ ($ vol)
MemberChamberTypeFiledTradedSize
Alan ArmstrongSenatepurchase2026-07-212026-03-27$1–15K
Ro KhannaHousesale2026-05-112026-04-24$1–15K
Elizabeth FletcherHousesale2026-05-012026-04-08$1–15K
Ro KhannaHousesale2026-04-072026-03-23$1–15K
Ro KhannaHousepurchase2026-04-072026-03-18$15–50K
Ro KhannaHousepurchase2026-03-092026-02-05$1–15K
Ro KhannaHousepurchase2026-02-062026-01-29$1–15K
Valerie HoyleHousesale2025-10-102025-09-23$1–15K
Valerie HoyleHousepurchase2025-09-122024-10-29$1–15K
Valerie HoyleHousesale2025-09-122025-04-29$1–15K
Valerie HoyleHousepurchase2025-09-122025-07-28$1–15K
Ro KhannaHousepurchase2025-05-122025-04-15$1–15K
Ro KhannaHousepurchase2025-05-122025-04-09$1–15K
Ro KhannaHousepurchase2025-05-122025-04-23$1–15K

Research tool, not investment advice — historical frequencies, not recommendations. Full terms.